How skeptical should you be of an after-the-fact subgroup analysis in a failed clinical trial?

This article was adapted from STAT’s latest report, “Subgroup analysis: how to evaluate post hoc tests for significance in failed clinical trials.”

Clinical trials of newly developed drugs often don’t work out.

Read the rest…

Read Original Article: How skeptical should you be of an after-the-fact subgroup analysis in a failed clinical trial? »